Discovery Laboratories, Inc. (NASDAQ:DSCO)

CAPS Rating: 3 out of 5

A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.

Recs

0
Player Avatar pchop123 (79.78) Submitted: 11/12/2012 5:09:16 PM : Outperform Start Price: $2.02 DSCO Score: -6.49

Nice buyin point, but they have to really work at moving up now

Featured Broker Partners


Advertisement